Ardelyx
Develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.
Launch date
Employees
Market cap
CAD2.0b
Enterprise valuation
CAD1.9b (Public information from Sep 2024)
Share price
$5.99 ARDX
Fremont California (HQ)
Authorizing premium user...